Legal Opinion
Eli Lilly & Co. v. Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center
Court of Appeals for the Federal Circuit
Decided February 28, 2017No. 2016-1547PublishedCited by 2 opinions
1Opinion of the Court
Bryson, Circuit Judge.
This appeal is related to the appeal in Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center v. Eli Lilly & Company, No. 2016-1518, 849 F.3d 1049, 2017 WL 765812, decided today. The same patent (U.S. Patent No. 8,133,-903 (“the ’903 patent”)) and one of the same prior art references (International Patent Application No. WO 01/80860 (published Nov. 1, 2001) (John S. Whitaker et al., applicants) (“Whitaker”)) are at issue in both cases. The background discussion set forth in the Los Angeles Biomedical Research Institute case will not be repeated here,…
2Cases cited4 opinions
- David M. Rapoport v. William C. Dement, Mark R. Rosekind, and Jeffrey L. SchwimmerCourt of Appeals for the Federal Circuit · 2001
- ClearValue, Inc. v. Pearl River Polymers, Inc.Court of Appeals for the Federal Circuit · 2012
- United States v. Joshua ElkinsCourt of Appeals for the Ninth Circuit · 2012
- Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center v. Eli Lilly & Co.Court of Appeals for the Federal Circuit · 2017
3Cited by2 opinions
- HTC Corp. v. Cellular Communications Equipment, LLCCourt of Appeals for the Federal Circuit · 2017
- Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center v. Eli Lilly & Co.Court of Appeals for the Federal Circuit · 2017